Audiomedica.com
Venetoclax Pro-Apoptotic Therapy Benefits Older Patients with Acute Myeloid Leukemia
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:05:00
- Mas informaciones
Informações:
Sinopsis
ATLANTA—Adding anti-BCL-2 therapy with the small-molecule drug venetoclax (VEN) to standard low-dose cytarabine (LDAC) chemotherapy tripled response rates over historical comparators and extended survival in older patients with acute myeloid leukemia (AML) who were ineligible for intensification of their chemotherapy …Andrew Wei INTEVIEW PRODUCTION MASTER
